Evidence map›Paper›PMID 20595413›Full record

ArticleThe American journal of psychiatry2010

The role of a prescription in anxiety medication use, abuse, and dependence.

Miriam C Fenton, Katherine M Keyes, Silvia S Martins, Deborah S Hasin

Open access · greenAbstract readComparative Study
In one paragraph

Article in The American journal of psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. A prospective study of adolescents' nonmedical use of anxiolytic and sleep medication.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miriam C FentonDepartment of Psychiatry, Columbia University, College of Physicians and Surgeons, 1051 Riverside Dr., New York, NY 10032, USA.
Katherine M Keyes
Silvia S Martins
Deborah S Hasin
Columbia University · US

Funding

Phenotypes for Drug Abuse:Epidemiologic-Genetic ApproachR01DA018652 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2004 to 2018
$5.3M
Predictors of Pathological Gambling among African-American Young AdultsR01HD060072 · NICHD · JOHNS HOPKINS UNIVERSITY · PI CANINO, GLORISA J, DUARTE, CRISTIANE S. · 2009 to 2018
$3.9M
Adverse childhood experiences, personality psychopathology, and alcohol disordersU01AA018111 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2009 to 2013
$3.4M
Epidemiologic Studies of Alcohol Use Disorders (ongoing)K05AA014223 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HASIN, DEBORAH S · 2003 to 2012
$1.5M
Trends in Problems Related to Extramedical Use of AnalgesicsR21DA020667 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MARTINS, SILVIA SABOIA · 2007 to 2008
$424k
Trends in NonMedical Prescription Drug Use, Abuse-Dependence in AdolescenceR03DA023434 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MARTINS, SILVIA SABOIA · 2008 to 2009
$164k
Age-period-cohort effects on substance use in adolescence, 1976-2006F31DA026689 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KEYES, KATHERINE M. · 2009 to 2009
$25k
NIAAA NIH HHS K05 AA014223NIAAA NIH HHS K05AA014223NIAAA NIH HHS U01 AA018111NIAAA NIH HHS U01AA018111NICHD NIH HHS R01 HD060072NICHD NIH HHS R01HD060072NIDA NIH HHS F31 DA026689NIDA NIH HHS F31-DA026689NIDA NIH HHS R01 DA018652NIDA NIH HHS R01DA018652NIDA NIH HHS R03DA02343NIDA NIH HHS R03 DA023434NIDA NIH HHS R21 DA020667NIDA NIH HHS R21DA020667
6 · The paper itself

Abstract

objectivePrescriptions for anxiety medications have increased substantially in recent years. Individuals with anxiety disorders are at risk of nonmedical use of these medications, but information about whether this risk is elevated among patients with a prescription for such medications is lacking. The authors compared risk of nonmedical use in individuals in a national sample with and without a prescription for anxiety medication and identified characteristics associated with nonmedical use.

methodData were drawn from face-to-face surveys of 34,653 adult participants in the National Epidemiologic Survey on Alcohol and Related Conditions. The risk of nonmedical use of prescription anxiety medication and associated drug use disorders was computed for individuals who had or had not ever received a prescription for anxiety medication; among those who had received a prescription, characteristics associated with nonmedical use were analyzed.

resultsPrescription of anxiety medication was associated with lifetime and past-year nonmedical use (odds ratios, 1.6 and 1.9, respectively) and lifetime DSM-IV abuse or dependence (odds ratio, 2.6). Among respondents who received a prescription (N=4,294), nonmedical use was associated with male sex, younger age, white race, history of use of illicit drugs, history of other drug use disorders, and history of illegal behaviors.

conclusionsThese results indicate that prescription for anxiety medications is associated with nonmedical use of these medications, although the direction of causality cannot be determined in this study. Although anxiety medications have clinical utility, greater clinical attention should be given to the potential for their abuse among patients at particular risk.

Indexed as

AdolescentAdultAnti-Anxiety AgentsAnxiety DisordersDrug PrescriptionsFemaleHumansIllicit DrugsMalePrescription DrugsPrevalenceProbabilityPsychiatric Status Rating ScalesSubstance-Related DisordersAnti-Anxiety AgentsIllicit DrugsPrescription Drugs

Identifiers

PMID20595413
PMCPMC3756550
OpenAlexW2170269536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.